Phase 3 Viti-Up trials show Rinvoq (upadacitinib) JAK inhibitor boosts facial and body repigmentation in nonsegmental ...
SMART-MASH found about a third more patients with cirrhosis than Agile 4 while using costly fibrosis tests in only some ...
After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates ...
ETNK1 fusion in MDS/MPN with eosinophilia; the fusion disappeared when disease relapsed as AML after transplant.
Liver disease disparities tied to insurance and race spanned HCC surveillance, transplant listing, and drug access in data at ...
A population-based study of 1102 Canadian children found infants with bone and soft tissue tumors had poorer survival, driven ...
Started at advanced fibrosis or cirrhosis, pegozafermin lowered liver collagen below baseline and prevented liver cancer in a ...
GOLD leaders say COPD is diagnosed too late and its smoking-only image is outdated, and the 2027 report puts rehab and ...
This week in health equity and access: Medicaid cuts; mailed FIT outreach; EEOC pregnancy rules; GLP-1 Bridge access; and ...
Resmetirom real-world data at The Liver Meeting 2026 show 12-month gains in liver stiffness, fat, and enzymes among patients ...
Most patients with CLL/SLL who discontinued a first-line BTK inhibitor did not start second-line therapy, and older age was ...
The proposal would bar common ownership of insurers or PBMs with medical providers or management services organizations, aiming to eliminate vertically integrated steering and self-dealing incentives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results